Reduced Dose-density of Denosumab for Unresectable GCTB
Clinical trial NCT03620149 · TERMINATED
Trial details
- NCT number
- NCT03620149
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-26
- Primary completion
- 2020-07-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.